Showing results (291-300 of 531) with videos related to
Sort By:
Pageof 54
European Heart Journal|June 10, 2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-PooledJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.Lancet (London, England)|October 1, 1994
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trialM J Sculpher, P Seed, R A Henderson, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2018
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trialsXavier Rossello, Cono Ariti, Stuart J Pocock, et al.Diabetologia|July 19, 2005
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocolP D Home, S J Pocock, H Beck-Nielsen, et al.European Heart Journal|February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialMichel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.International Journal of Surgery (London, England)|July 22, 2014
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationJan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.Journal of the American College of Cardiology|September 14, 2019
In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation Acute Coronary SyndromeHéctor Bueno, Xavier Rossello, Stuart J Pocock, et al.Epidemiology (Cambridge, Mass.)|December 1, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationJan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.BMJ (Clinical Research Ed.)|October 8, 2004
Issues in the reporting of epidemiological studies: a survey of recent practiceStuart J Pocock, Timothy J Collier, Kimberley J Dandreo, et al.JAMA|May 3, 2007
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized TrialAlexandre Mebazaa, Markku S Nieminen, Milton Packer, et al.Pageof 54